Aktis Oncology, Inc. — Institutional Ownership

Which tracked institutions hold AKTS, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

21
Funds holding
$171437561
Total value held
Buying
18 added/new · 2 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $73431479 2278358 +166231 +7.87%
2 Merck & Co., Inc. $30710162 952844 Held
3 Janus Henderson Group Plc $26022437 1454267 +1454267 NEW BUY
4 State Street Corp $15599642 484010 +55757 +13.02%
5 Northern Trust Corp $5819933 180575 +31099 +20.81%
6 Barclays Plc $4889163 151696 +141972 +1460.02%
7 Ubs Group Ag $3221711 99960 +99960 NEW BUY
8 Bank Of America Corp /De/ $2347472 72835 +2909 +4.16%
9 Morgan Stanley $2018758 62636 +31913 +103.87%
10 Raymond James Financial Inc $1626455 50464 +50464 NEW BUY
11 Bank Of New York Mellon Corp $1587324 49250 +6349 +14.80%
12 Wells Fargo & Company/Mn $891450 27659 +20048 +263.41%
13 Goldman Sachs Group Inc $685790 21278 -8885 -29.46%
14 Ameriprise Financial Inc $644600 20000 +20000 NEW BUY
15 Sei Investments Co $528515 16402 +16402 NEW BUY
16 Invesco Ltd. $480485 14908 +14908 NEW BUY
17 Citigroup Inc $424695 13177 +13177 NEW BUY
18 Jpmorgan Chase & Co $266021 8835 +480 +5.75%
19 Pnc Financial Services Group, Inc. $197893 6140 -808 -11.63%
20 Royal Bank Of Canada $25000 797 +797 NEW BUY
21 Fifth Third Bancorp $18576 576 +576 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.